U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C24H31NO4S
Molecular Weight 429.572
Optical Activity UNSPECIFIED
Defined Stereocenters 2 / 2
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of AGANEPAG

SMILES

CCCCC[C@H](O)C1=CC=C(C=C1)N2[C@@H](CCCC3=CC=C(S3)C(O)=O)CCC2=O

InChI

InChIKey=WXWCSPFQIXPFLD-RXVVDRJESA-N
InChI=1S/C24H31NO4S/c1-2-3-4-8-21(26)17-9-11-19(12-10-17)25-18(13-16-23(25)27)6-5-7-20-14-15-22(30-20)24(28)29/h9-12,14-15,18,21,26H,2-8,13,16H2,1H3,(H,28,29)/t18-,21-/m0/s1

HIDE SMILES / InChI

Molecular Formula C24H31NO4S
Molecular Weight 429.572
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 2 / 2
E/Z Centers 0
Optical Activity UNSPECIFIED

Aganepag is a potent Prostanoid EP2 receptor agonist, with an EC50 of 0.19 nM, and shows no activity at EP4 receptor. Aganepag can be used in the research of wound healing, scar reduction, scar prevention and wrinkle treatment and prevention. Aganepag is an antiglaucoma agent.

Approval Year

PubMed

PubMed

TitleDatePubMed
Patents

Sample Use Guides

Aganepag (Compound 3) is a potent Prostanoid EP2 receptor agonist, with an EC50 of 0.19 nM
Substance Class Chemical
Created
by admin
on Fri Dec 15 19:16:10 GMT 2023
Edited
by admin
on Fri Dec 15 19:16:10 GMT 2023
Record UNII
ODT7ZEW9O7
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
AGANEPAG
INN   USAN   WHO-DD  
INN   USAN  
Official Name English
Aganepag [WHO-DD]
Common Name English
AGN-210937
Code English
5-(3-((2S)-1-(4-((1S)-1-HYDROXYHEXYL)PHENYL)-5-OXOPYRROLIDIN-2-YL)PROPYL)THIOPHENE-2- CARBOXYLIC ACID
Systematic Name English
AGANEPAG [USAN]
Common Name English
2-THIOPHENECARBOXYLIC ACID, 5-(3-((2S)-1-(4-((1S)-1-HYDROXYHEXYL)PHENYL)-5-OXO-2- PYRROLIDINYL)PROPYL)-
Common Name English
aganepag [INN]
Common Name English
Code System Code Type Description
USAN
YY-24
Created by admin on Fri Dec 15 19:16:10 GMT 2023 , Edited by admin on Fri Dec 15 19:16:10 GMT 2023
PRIMARY
FDA UNII
ODT7ZEW9O7
Created by admin on Fri Dec 15 19:16:10 GMT 2023 , Edited by admin on Fri Dec 15 19:16:10 GMT 2023
PRIMARY
NCI_THESAURUS
C174796
Created by admin on Fri Dec 15 19:16:10 GMT 2023 , Edited by admin on Fri Dec 15 19:16:10 GMT 2023
PRIMARY
SMS_ID
300000034070
Created by admin on Fri Dec 15 19:16:10 GMT 2023 , Edited by admin on Fri Dec 15 19:16:10 GMT 2023
PRIMARY
INN
9400
Created by admin on Fri Dec 15 19:16:10 GMT 2023 , Edited by admin on Fri Dec 15 19:16:10 GMT 2023
PRIMARY
PUBCHEM
24759922
Created by admin on Fri Dec 15 19:16:10 GMT 2023 , Edited by admin on Fri Dec 15 19:16:10 GMT 2023
PRIMARY
CAS
910562-18-4
Created by admin on Fri Dec 15 19:16:10 GMT 2023 , Edited by admin on Fri Dec 15 19:16:10 GMT 2023
PRIMARY
ChEMBL
CHEMBL2103861
Created by admin on Fri Dec 15 19:16:10 GMT 2023 , Edited by admin on Fri Dec 15 19:16:10 GMT 2023
PRIMARY
Related Record Type Details
TARGET -> AGONIST
Related Record Type Details
PRODRUG -> METABOLITE ACTIVE
PRODRUG -> METABOLITE ACTIVE
Related Record Type Details
ACTIVE MOIETY